New risk score predicts heart disease in patients with chest pain

June 12, 2012

A new risk prediction tool can identify patients at high risk of coronary artery disease who might need further diagnostic work, says a study published on BMJ today. The tool is more accurate than existing models and could be easily integrated into electronic patient records or mobile applications.

Coronary artery disease is a major cause of death throughout the world. It occurs when the arteries supplying oxygen and nutrients to the heart become narrowed with .

Chest pain may be the first sign of the condition so current guidelines recommend using one of two (the Diamond & Forrester model or the Duke Clinical Score) for patients with chest pain to help doctors estimate their risk and decide if further tests are needed.

However, questions about the accuracy of these tools have been raised.

So a team of European researchers decided to develop an improved prediction model using a range of variables with known links to coronary artery disease. They analysed data for 5,677 patients (3,283 men and 2,394 women) with chest pain but no previous history of heart disease from 18 hospitals across Europe and the USA.

Their basic model predicted coronary artery disease according to age, sex and symptoms. A clinical model included risk factors such as diabetes, high blood pressure, elevated lipid levels and smoking, while an extended model added the coronary calcium score (a measure of calcium in the coronary arteries that is associated with the presence of coronary artery disease and also determines the risk of a coronary event).

Their results suggest that the Duke Clinical Score (the tool that is currently recommended by the NICE guideline) significantly overestimates the probability of coronary artery disease.

Their clinical model improves these estimates, predicting probabilities between 2% for a 50 year old female with non-specific chest pain and no risk factors and 91% for an 80 year old male with typical chest pain and multiple risk factors.

Adding the coronary calcium score improved the prediction event further.

In addition, their model does not require resting heart (ECG) readings, making it better suited for use in primary practice, while an online calculator, also developed by the team, could be easily integrated into or .

Because the implementation of the NICE guidelines requires an accurate estimate of the probability of , the authors conclude that their model "allows doctors to make better decisions as to which diagnostic test is best in a particular patient and to decide on further management based on the results of such tests."

Related Stories

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.